1. Home
  2. VATE vs IMRX Comparison

VATE vs IMRX Comparison

Compare VATE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • IMRX
  • Stock Information
  • Founded
  • VATE 1994
  • IMRX 2008
  • Country
  • VATE United States
  • IMRX United States
  • Employees
  • VATE N/A
  • IMRX N/A
  • Industry
  • VATE Metal Fabrications
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • IMRX Health Care
  • Exchange
  • VATE Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • VATE 63.4M
  • IMRX 62.7M
  • IPO Year
  • VATE 1996
  • IMRX 2021
  • Fundamental
  • Price
  • VATE $5.11
  • IMRX $2.02
  • Analyst Decision
  • VATE
  • IMRX Buy
  • Analyst Count
  • VATE 0
  • IMRX 7
  • Target Price
  • VATE N/A
  • IMRX $12.80
  • AVG Volume (30 Days)
  • VATE 59.8K
  • IMRX 4.9M
  • Earning Date
  • VATE 03-03-2025
  • IMRX 02-28-2025
  • Dividend Yield
  • VATE N/A
  • IMRX N/A
  • EPS Growth
  • VATE N/A
  • IMRX N/A
  • EPS
  • VATE N/A
  • IMRX N/A
  • Revenue
  • VATE $1,231,500,000.00
  • IMRX N/A
  • Revenue This Year
  • VATE N/A
  • IMRX N/A
  • Revenue Next Year
  • VATE N/A
  • IMRX N/A
  • P/E Ratio
  • VATE N/A
  • IMRX N/A
  • Revenue Growth
  • VATE N/A
  • IMRX N/A
  • 52 Week Low
  • VATE $3.25
  • IMRX $1.00
  • 52 Week High
  • VATE $10.80
  • IMRX $7.68
  • Technical
  • Relative Strength Index (RSI)
  • VATE 47.68
  • IMRX 47.82
  • Support Level
  • VATE $4.72
  • IMRX $1.84
  • Resistance Level
  • VATE $5.77
  • IMRX $3.80
  • Average True Range (ATR)
  • VATE 0.37
  • IMRX 0.29
  • MACD
  • VATE -0.04
  • IMRX -0.03
  • Stochastic Oscillator
  • VATE 35.78
  • IMRX 9.18

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: